Generative AI in Healthcare Market is boom to US$ 30.68 Billion by 2033, at very strong CAGR of 35.1% . North America leads the market with 40.2% market share.

Generative AI in Healthcare Market Size reached US$ 2.92 Billion in 2024 and is expected to reach US$ 30.68 Billion by 2033, growing at a CAGR of 35.1% during the forecast period 2025-2033,

The Generative AI in Healthcare Market is growing due to AI-driven drug discovery, personalized treatment plans, advanced diagnostics, and automated clinical workflows, enhancing efficiency, accuracy, and cost-effectiveness in patient care globally.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/generative-ai-in-healthcare-market?prtk
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

United States: Key Industry Developments

✅ January 2026: Amazon introduced its new Health AI, a generative AI‐powered personalized medical assistant integrated with the One Medical app, designed to use patient history for continuous care and streamline healthcare interactions.

✅ November 2025: IBM Watson Health launched a new GenAI clinical decision support platform, backed by extensive U.S. R&D and cloud investment, aimed at assisting physicians with diagnosis support and personalized treatment planning.

✅ October 2025: Google Health completed the acquisition of a U.S. AI healthcare startup specializing in generative models for radiology and pathology, ramping up capabilities for imaging analysis and predictive patient outcomes.

✅ September 2025: Microsoft Healthcare partnered with major U.S. health systems to deploy generative AI for patient data synthesis and clinical trial optimization, accelerating research and improving clinical workflows.

Japan: Key Industry Developments

✅ May 2025: Hippocratic AI and EUCALIA partnered to launch the first Japanese‐language generative AI healthcare agent, designed for non‐diagnostic, patient‐facing tasks such as scheduling, follow‐ups, and medication support marking a major product introduction in Japan's healthcare AI market.

✅ November 2025: Fujitsu unveiled a generative AI platform for EHR and patient data analysis with substantial domestic R&D investment, enhancing clinical workflows and decision support across Japanese hospitals.

✅ October 2025: NEC Corporation completed acquisition of a domestic healthcare AI startup to integrate generative AI into medical imaging and predictive diagnostics, expanding Japan's generative AI capabilities in healthcare tech.

✅ October 2025: A specialized cardiac hospital in Tokyo launched "New Heart AI", a generative AI‐powered chatbot providing 24/7 patient information on cardiac conditions, treatments, and services, reflecting novel patient engagement tech.

▶ Recent M&A activities:-
→ In January 2026, OpenAI acquired healthcare AI startup Torch Health in a deal valued at approximately $100 million.
This acquisition strengthens OpenAI's generative AI capabilities for healthcare platformsparticularly the newly launched ChatGPT Healthby integrating Torch's medical data and patient context technology into OpenAI's AI‐driven health offerings.

→ On January 12, 2026, Hippocratic AI acquired Grove AI (terms undisclosed).
Hippocratic AI, a generative AI healthcare company, purchased Grove AIa startup focused on agentic AI for pharma research & clinical trial operationsto expand its life sciences AI stack and accelerate end‐to‐end AI adoption in R&D and patient engagement workflows. Financial details were not publicly disclosed.

→ In November 2025, Hippocratic AI raised $126 million in Series C funding to fuel strategic M&A and growth.
While not itself an acquisition, this financing round at a $3.5 billion valuation clarified the company's intent to use proceeds for future mergers and acquisitions in the generative healthcare AI space.

→ In August 2025, Tempus AI acquired digital pathology leader Paige for $81.25 million.
Tempus AI, which leverages artificial intelligence in healthcare diagnostics, bought Paige to integrate advanced digital pathology capabilities into its GenAI‐enabled precision medicine and analytics offerings.

▶ Key Players:-
IBM, Google LLC, Microsoft, OpenAI, NVIDIA Corporation, Oracle, Johnson & Johnson Services, Inc., NioyaTech, and Saxon. among others.

Top 5 Key Players Analysis:-
IBM - Holds a significant share with its AI-powered healthcare solutions like Watson Health, focusing on diagnostics and clinical decision support.

Google LLC - Strong market presence with AI applications in medical imaging and predictive healthcare analytics through Google Health.

Microsoft - Leverages Azure AI and cloud-based healthcare solutions, capturing a growing share in enterprise healthcare AI services.

OpenAI - Emerging player providing advanced generative AI models for medical research, clinical insights, and patient engagement tools.

NVIDIA Corporation - Key contributor with GPU-accelerated AI platforms for medical imaging, genomics, and AI-driven drug discovery.

▶ Tech & Strategic Partnerships:-
Microsoft & Healthcare Integration Partners
Microsoft expands Dragon Copilot AI tools for nurses & care teams to reduce workflow burden and improve patient care. This initiative includes multiple partner integrations with healthcare solution providers.

WellSpan Health + General Catalyst
WellSpan Health extended its partnership with General Catalyst to test and scale advanced AI technologies across hospital systems, particularly to address staffing shortages and operational bottlenecks.

Strategic Tech Partnerships Transforming Healthcare Operations
AHA notes a surge in tech partnerships aimed at streamlining administrative workflows and enabling value‐based care models using advanced AI tools.

Omega Healthcare & Microsoft
Omega Healthcare deepened its collaboration with Microsoft to accelerate generative AI and agentic AI capabilities in revenue cycle management (RCM) - enhancing automation and financial operations.

KPMG & Hippocratic AI
KPMG announced a collaboration with Hippocratic AI to transform healthcare delivery by leveraging AI healthcare agents, targeting workforce shortages and digital transformation

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=generative-ai-in-healthcare-market?prtk

▶ Market Drivers :-
⏩ AI‐powered ambient documentation solutions capture physician-patient interactions in real time, reducing administrative time and burnout.

⏩ Workflow automation is cited as a core pull for healthcare providers seeking operational relief without expanding staff.

⏩ Generative AI improves the accuracy and efficiency of image interpretation, supporting earlier and more precise disease detection.

⏩ Imaging analysis segments alone accounted for nearly 30% of market revenue in 2024.

⏩ Demand for personalized therapies is significantly boosting investment and adoption of AI solutions.

⏩ Advanced predictive analytics improve treatment outcomes by understanding nuanced patient profiles

⏩ Forecasts show generative AI reducing drug development time by up to 40%.

⏩ The drug discovery segment continues to capture a large share of research budgets.

⏩ Embedding generative AI into core healthcare IT (e.g., EHR platforms) enhances scalability and adoption.

⏩ Hospitals, specialty clinics, and research institutes increasingly incorporate AI into daily workflows.

▶ Regional Insights:-

1. North America
• North America holds the largest share of the generative AI in healthcare market, commanding around 40.2% of global revenue in 2024 due to strong healthcare infrastructure and high tech adoption.
• The U.S. specifically drives leadership with advanced AI deployment in clinical workflows and significant R&D investments.

2. Europe
• Europe is the second-largest regional market, accounting for approximately 28.6% of the global market share in 2024 supported by structured healthcare systems and regulatory frameworks.
• Growth is fueled by AI adoption in diagnostics, personalized medicine, and chronic disease management across countries like Germany, the UK, and France.

3. Asia Pacific
• Asia Pacific holds around 21.6% of the global generative AI healthcare market in 2024 and is projected to be the fastest-growing region with high CAGR forecasts.
• Rapid digital healthcare adoption, government support, and rising patient volumes in China, India, and Japan drive expansion.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/generative-ai-in-healthcare-market?prtk

▶ Market Segmentation

By Component:
Solutions: AI platforms, software, and tools that assist in diagnostics, drug discovery, and treatment planning.
Services: Implementation, consulting, and support services for AI integration in healthcare systems.

By Application:
Diagnostics & Medical Imaging: Enhances image analysis and disease detection accuracy.
Drug Discovery & Development: Speeds up molecular research, testing, and new drug development.
Personalized Treatment: Enables customized therapy plans based on patient data.
Patient Monitoring & Predictive Analytics: Tracks patient health and predicts risks for better care.
Others: Includes administrative support, workflow optimization, and clinical decision assistance.

By End-User:
Hospitals & Clinics: Deploy AI for improved patient care and operational efficiency.
Healthcare Organizations: Integrate AI solutions for large-scale healthcare management.
Diagnostic Centers: Use AI for faster and more accurate test results.
Others: Includes research labs, telemedicine providers, and pharmaceutical companies.

FAQ'S:-
Q1: What is generative AI in healthcare?
A: AI that creates new medical data, insights, or solutions, like drug designs, patient simulations, or treatment plans.

Q2: How is the market growing?
A: Driven by AI adoption in diagnostics, drug discovery, and personalized medicine, boosting efficiency and innovation.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.